Sobuzoxane

DB21119ExperimentalSmall molecule

Sobuzoxane is a small molecule drug. The usage of the INN stem '-oxan(e)' in the name indicates that Sobuzoxane is a benzodioxane derivative. Sobuzoxane has a monoisotopic molecular weight of...

Mechanism: Pharmacologically active on DNA topoisomerase 2
Curator reviewed
Formula / weight: C₂₂H₃₄N₄O₁₀ · 514.532 g/mol (avg)

Resolves to

Compound

UNIIR1308VH37PCAS98631-95-9ChEMBLCHEMBL1256871ChEBI32136

Structure

InChIKeyOCOKWVBYZHBHLU-UHFFFAOYSA-NSMILESCC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O

What you can answer from here — as of September 19, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which companies are running trials of Sobuzoxane, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account